Ads
related to: aimovig launch- Dosing & Administration
Learn More About Dosing & Efficacy
On The Healthcare Provider Site.
- Practitioner Resources
Explore Physician Resources To Help
Patients Start & Stay On Aimovig®
- AimAlly™ for Your Patient
View AimAlly™ Tools & Resources To
Provide Your Patients With Support.
- MDs: Support Your Patient
Discover Coverage Options & Provide
Your Patients With Access & Support
- Dosing & Administration
Search results
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug
Investor's Business Daily· 6 months agoAmgen handily beat Wall Street's earnings forecasts Tuesday, but Amgen stock tumbled after the...
Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 12 months agoAmgen AMGN reported first-quarter 2023 earnings of $3.98 per share, which beat the Zacks Consensus...
Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoFor new and old investors, taking full advantage of the stock market and investing with confidence...
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
Zacks via Yahoo Finance· 2 years agoAmgen AMGN reported second-quarter 2022 earnings of $4.65 per share, which beat the Zacks Consensus...
Amgen 1st quarter profit falls as costs rise, sales up 2%
Reuters via Yahoo Finance· 12 months ago(Reuters) -Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2%...
Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 month agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 6 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...
Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAmgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript January 31, 2023 Amgen Inc. misses on...
Ads
related to: aimovig launch